Appendices

Appendix C: Travel Vaccine Summary Table

David R. Shlim

Table C-01 is a quick reference for administering or prescribing travel-related vaccines. Before administering any vaccine, please review detailed instructions, precautions, and side effects under the specific vaccines discussed in this book or in the manufacturer’s package insert. For other immunizations, refer to the corresponding disease section in Chapter 3.

Table C-01. Travel vaccine summary

VACCINE	BRAND	DOSE	ROUTE	SCHED- ULE	BOOSTER	AGE
Hepatitis A (adults)	Havrix Vaqta	1.0 mL (1,440 ELISA units) 1.0 mL (50 units)	IM IM	0 and 6–12 months 0 and 6–18 months	None None	≥19 years ≥19 years
Hepatitis A (pediatric)	Havrix Vaqta	0.5 mL (720 ELISA units) 0.5 mL (25 units)	IM IM	0 and 6–12 months 0 and 6–18 months	None None	1–18 1–18
Combined hepatitis A and hepatitis B	Twinrix	1.0 mL (20μg of hepatitis B antigen and 720 ELISA units of hepatitis A antigen)	IM	0, 1 month, and 6 months; acceler- ated schedule: days 0, 7, and 21, with a fourth dose at 12 months	None	≥18 years
Japanese encepha- litis	Ixiaro	0.5 mL	IM	0 and 28 days	≥1 year after primary series	≥17 years
Meningo- coccal conjugate (MenACWY)	Menactra (MenACWY_D) (Updated January 25, 2012) Menveo (MenACWY_CRM) (Updated January 25, 2012)	0.5 mL 0.5 mL 0.5 mL	IM IM IM	2 dose primary series separated by 3 months 1 dose 1 dose	See Chapter 3, Meningo- coccal Disease See Chapter 3, Meningo- coccal Disease See Chapter 3, Meningo- coccal Disease	9-23 months 2–55 years 2–55 years
Meningo- coccal polysac- charide (MPSV4)	Meno- mune	0.5 mL	SQ	1 dose	See Chapter 3, Meningo- coccal Disease	≥2 years
Inacti- vated polio (adult)	Ipol	0.5 mL	SQ or IM	One dose at >18 years, if patient has already had an accept- able polio vaccine series	None	≥18 years¹
Rabies	Imovax RabAvert	1.0 mL 1.0 mL	IM IM	Pre-exposure series; Days 0, 7, and 28 Pre-exposure series; Days 0, 7, and 28	See Chapter 3, Rabies See Chapter 3, Rabies	No age restric- tions No age restric- tions
Typhoid capsular polysac- charide	Typhim Vi	0.5 mL	IM	1 dose	Every 2 years	≥2 years
Typhoid oral, live, attenu- ated	Vivotif	1 pill	Oral	1 pill every other day for 4 doses	Every 5 years	≥6 years
Yellow fever	YF-Vax	0.5 mL	SQ	1 dose	Every 10 years	≥9 months, same dose for children and adults²

Abbreviations: ELISA, enzyme-linked immunosorbent assay; IM, intramuscular; SQ, subcutaneous.

¹For catch-up immunization in pediatric population, see Table 7-4.
²Special considerations apply in deciding whether to administer yellow fever vaccine. Please review Chapter 3, Yellow Fever before administration. Yellow fever vaccine is never given to infants <6 months and is given only under special circumstances for ages 6–8 months.

(Updated September 1, 2011)